This case highlights the potential severity of neuroleptic malignant syndrome in patients with multiple risk factors taking antipsychotics and other dopaminergic medications.
No takes yet. Share an insight, caveat, or question.
May warrant NMS vigilance in patients on antipsychotics plus dopaminergic agents; hypothesis-generating case report that leaves risk magnitude open.
McCullough et al. (2013) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: